SCHEMBL19852294

SCHEMBL19852294

CCC1(C)CC(O)(c2ccccc2)CO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.40
SLC6A2 P23975 2/20 0.40
CHRNB4 P30926 2/20 0.40
CHRNA3 P32297 2/20 0.40
CHRNA4 P43681 2/20 0.40
SLC6A3 Q01959 2/20 0.40
OPRL1 P41146 8/20 0.38
OPRM1 P35372 7/20 0.38
OPRK1 P41145 7/20 0.38
GRIN2B Q13224 1/20 0.38
CYP1A2 P05177 1/20 0.37
OPRD1 P41143 6/20 0.37
TSHR P16473 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HTR1A P08908 1/20 0.36
HTR7 P34969 1/20 0.36
HTR6 P50406 1/20 0.36
GAA P10253 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8990373 0.78 CHRNB2 (0.46) CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4
SCHEMBL9876612 0.69 SLC6A2 (0.35) CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4
SCHEMBL34468465 0.66 OPRL1 (0.50) OPRL1OPRM1OPRK1GRIN2BOPRD1
SCHEMBL11467643 0.66 OPRL1 (0.47) OPRL1OPRM1OPRK1GRIN2BCYP1A2
SCHEMBL6493723 0.66 MEN1 (0.40) CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4
SCHEMBL6493726 0.66 MEN1 (0.40) CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4
SCHEMBL16823462 0.65 OPRL1 (0.45) CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4
SCHEMBL9876519 0.65 POLB (0.46) CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4
SCHEMBL9022765 0.64 OPRL1 (0.48) OPRL1OPRM1OPRK1OPRD1TSHR
SCHEMBL2708067 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed